Log In
Print this Print this

Orsiro Hybrid Drug-Eluting Stent

  Manage Alerts
Collapse Summary General Information
Company Biotronik SE & Co. KG
DescriptionBIOlute-coated stent using a limus drug delivered by bioabsorbable matrix
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today